Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03053830 · ClinicalTrials.gov registry record · Phase 2
Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
A Phase 2 study, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT03053830: Completed Phase 2 study, sponsored by VA Connecticut Healthcare System.
NCT03053830 is a Phase 2 study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03053830, a Phase 2 study, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
Medically healthy Veterans ages 21-75 that have been diagnosed with Depression will get up to 6 treatments of Ketamine infusions, weekly. After treatment is completed, follow up will occur at 1 month, 3 months, and 6 months after completion of infusions to evaluate the longer term effects of ketamine.
Interventions
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-01-31 |
| Est. Completion | 2018-09-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03053830
The ClinicalTrials.gov registry entry for NCT03053830 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine is the first listed.
NCT03053830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03053830 about?
NCT03053830 is a clinical study titled "Open Label Ketamine Treatment for Major Depressive Disorder in Veterans". Medically healthy Veterans ages 21-75 that have been diagnosed with Depression will get up to 6 treatments of Ketamine infusions, weekly. After treatment is completed, follow up will occur at 1 month, 3 months, and 6 months after completion of infusions to evaluate the longer term effects of ketamin...
What is the current status of trial NCT03053830?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2017-01-31. Estimated completion is 2018-09-26.
What interventions are being tested in trial NCT03053830?
The interventions under investigation include: Ketamine (DRUG).
Who is sponsoring clinical trial NCT03053830?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.